Prajwal C Boddu
15PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Oct 29, 2025
Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.Cameron J Hunter, Wei Cheng, Jan Philipp Bewersdorf
|Nov 30, 2022
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.Prajwal C Boddu, Jayastu Senapati, Farhad Ravandi-Kashani
|Aug 20, 2019
Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.Rory M Shallis, Jan Philipp Bewersdorf, Prajwal C Boddu
|May 25, 2019
Outcomes of patients with chronic phase chronic myeloid leukemia (CML-CP) after discontinuation of frontline ponatinib therapy.Prajwal Boddu, Preetesh Jain, Gautam Borthakur
|Feb 28, 2019
Janus kinase 2 variants associated with the transformation of myeloproliferative neoplasms into acute myeloid leukemia.Christopher B Benton, Prajwal C Boddu, Courtney D DiNardo
|Dec 07, 2018
Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes.Prajwal C Boddu, Tapan M Kadia, Guillermo Garcia-Manero
Pageof 3
Frequent Collaborators
6 joint publications
Tapan M Kadia
4 joint publications
Gautam Borthakur
4 joint publications
Elias Jabbour
4 joint publications
Hagop M Kantarjian
2 joint publications
Naveen Pemmaraju
2 joint publications
Rashmi Kanagal-Shamanna
2 joint publications
Jan Philipp Bewersdorf
2 joint publications
Rory M Shallis
1 joint publications
Ahmad Alhuraiji
1 joint publications
Jorge Cortes
